WHO ICTRP trial
Effect of SGLT2 inhibitor to epicardial adipose tissue thickness in patient with…
KCT0008535 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0008535 |
|---|---|
| Public title | Effect of SGLT2 inhibitor to epicardial adipose tissue thickness in patient with heart failure with left ventricular ejection fraction over 40% and increased epicardial adipose tissue thickness |
| Scientific title | Effect of SGLT2 inhibitor to epicardial adipose tissue thickness in patient with heart failure with left ventricular ejection fraction over 40% and increased epicardial adipose tissue thickness |
| Primary sponsor | Kangbuk Samsung Medical Center |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Phase4 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the circulatory system |
| Interventions | Drug : The study is scheduled to be conducted on adults aged 19 to less than 85 years with an increased epicardial fat thickness of 5 mm or more on transthoracic echocardiography among heart failure patients with an increased left… |
| Registration date | Jun 16, 2023 |
| Target size | 30 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: